5-Methyl-2-phenyl-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

2-((5-Chloropyridin-3-yl)oxy)ethan-1-amine dihydrochloride, 95%, 250mg

2-(3-((3-Fluorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 100mg

2,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 97%, 100mg

1,4-butanodiol, mínimo 99,0%, para síntesis, 1L, envase de vidrio

(4-Iodo-3-methylphenyl)methanol, 98%, 250mg

2-(3-methylpiperidin-1-yl)propanoic acid, 95.0%, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)5g

3'-Carboethoxy-2-piperidinomethyl benzophenone, 97.0%, 1g

7-(Trifluoromethyl)isatin>98.0%(GC)(T)5g

4-((4-(tert-Butyl)phenylsulfonamido)methyl)-N-(pyridin-3-yl)benzamide, 98%, 1g

2-Bromo-6-iodopyridine, 97.0%, 250mg

2-Cyano-N-methyl-n-phenylacetamide, 98.0%, 1g